From July 1, 2023 to September 30, 2023, the company has repurchased 4,148,600 shares, representing 0.55% for CNY 29.56 million. With this, the company has completed the repurchase of 14,148,600 shares, representing 1.84% for CNY 100.02 million under the buyback announced on May 9, 2023.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
6.46 CNY | -0.77% | -4.86% | -6.38% |
1st Jan change | Capi. | |
---|---|---|
-6.38% | 648M | |
+20.08% | 22.46B | |
+18.55% | 15.04B | |
+18.94% | 13.98B | |
+56.80% | 13.15B | |
-10.55% | 6.89B | |
-0.05% | 6.79B | |
-8.87% | 5.73B | |
+13.66% | 5.71B | |
+4.00% | 4.69B |
- Stock Market
- Equities
- 600351 Stock
- News Yabao Pharmaceutical Group Co., Ltd
- Tranche Update on Yabao Pharmaceutical Group Co., Ltd's Equity Buyback Plan announced on May 9, 2023.